Methocarbamol and Cefuroxime drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Methocarbamol (methocarbamol) and Cefuroxime (cefuroxime sodium). Common drug interactions include dizziness among females and renal failure among males.
The phase IV clinical study analyzes what interactions people have when they take Methocarbamol and Cefuroxime. It is created by eHealthMe based on reports of 68 people who take the same drugs from the FDA, and is updated regularly.
What is Methocarbamol?
Methocarbamol has active ingredients of methocarbamol. It is often used in muscle spasms. eHealthMe is studying from 17,766 Methocarbamol users. Check the latest studies of Methocarbamol.
What is Cefuroxime?
Cefuroxime has active ingredients of cefuroxime sodium. It is often used in sinusitis. eHealthMe is studying from 12,999 Cefuroxime users. Check the latest studies of Cefuroxime.
68 people who take Methocarbamol and Cefuroxime together, and have interactions are studied.

What are the common drug interactions of Methocarbamol and Cefuroxime, by gender? *:
female:
- Dizziness
- Drug dependence
- Dyskinesia (abnormality or impairment of voluntary movement)
- Emotional disorder
- Extrapyramidal disorder (involuntary muscle spasms in the face and neck)
- Headache (pain in head)
- Hypotension (abnormally low blood pressure)
- Injury
- Nausea (feeling of having an urge to vomit)
- Rash
male:
- Renal failure (kidney dysfunction)
- Chronic kidney disease
- Multiple fractures
- Activated partial thromboplastin time prolonged
- Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Bleeding varicose vein
- Blood potassium decreased
- Blood sodium decreased
- Cardiac disorder
What are the common drug interactions of Methocarbamol and Cefuroxime, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Chronic kidney disease
40-49:
- Chronic kidney disease
- Renal failure (kidney dysfunction)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Decreased activity
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Depression
- Dyspepsia (indigestion)
- Emotional distress
50-59:
- Renal injury (kidney injury)
- Depression
- Bone density decreased
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
- Multiple fractures
- Impaired work ability
- Nephrogenic anaemia (anaemia due to kidney disease)
- Nephropathy (damage to or disease of a kidney)
- Osteoporosis (bones weak and more likely to break)
- Rash
60+:
- Chronic kidney disease
- Renal failure (kidney dysfunction)
- Anxiety
- Gait disturbance
- Injury
- Nephrogenic anaemia (anaemia due to kidney disease)
- Stress fracture (fracture of a bone caused by repeated (rather than sudden) mechanical stress)
- Vitamin d deficiency
- Weight decreased
- Activated partial thromboplastin time prolonged
What are the existing conditions these people have? *
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 39 people, 57.35%
- Pain: 28 people, 41.18%
- High Blood Pressure: 28 people, 41.18%
- High Blood Cholesterol: 26 people, 38.24%
- Stress And Anxiety: 21 people, 30.88%
- Nausea (feeling of having an urge to vomit): 18 people, 26.47%
- Depression: 17 people, 25.00%
- Infection: 15 people, 22.06%
- Asthma: 15 people, 22.06%
- Hypersensitivity: 15 people, 22.06%
* Approximation only. Some reports may have incomplete information.
Do you take Methocarbamol and Cefuroxime?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Methocarbamol (17,766 reports)
- Cefuroxime (12,999 reports)
Browse all drug interactions of Methocarbamol and Cefuroxime:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Methocarbamol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Cefuroxime:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Methocarbamol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cefuroxime and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on methocarbamol and cefuroxime sodium (the active ingredients of Methocarbamol and Cefuroxime, respectively), and Methocarbamol and Cefuroxime (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Zegerid cause Weakness? - 3 seconds ago
- Could B12 cause Uterine Polyp? - 8 seconds ago
- Could Jevtana cause Cardiac Arrest? - 12 seconds ago
- Could Opdivo cause Myositis? - 15 seconds ago
- Could Infergen cause Acute Kidney Failure? - 22 seconds ago
- Relapsing-Remitting Multiple Sclerosis and Blood Immunoglobulin M Decreased - 26 seconds ago
- Drug interactions of Fioricet and Accupril - 34 seconds ago
- Could Celexa cause Dental Care? - 37 seconds ago
- Drug interactions of Nolvadex and Allopurinol - 50 seconds ago
- Drug interactions of Flonase and Diazepam - 51 seconds ago